Main menu

Language

Anonymous's groups in this site

User is not a member of any group.

Your groups across all your sites

User is not a member of any group.

Recent Content

Biden administration races to alocate $74bn in climate funding but $20bn remains vulnerable to Trump rollback

Recent Comments

More details of Trump administration's proposed budget cuts 1 week 3 days ago
Analysis: New CDC Covid statements appear to contradict Kennedy 2 weeks 21 hours ago
The universal flu vaccine project puzzles vaccine experts 1 month 1 day ago
New uncertainty into approval of new COVID boosters 1 month 2 weeks ago

Who's online

There are currently 0 users online.

You are here

Trump administration's FDA signals uncertainty about approving future COVID vaccines

Primary tabs

Wed, 2025-04-30 15:52 — mike kraft

FDA chief says they're looking at whether to approve COVID shots for next winter FDA Commissioner Dr. Marty Makary said there is a "void of data" on the COVID booster shots. CBS News

...

His answer marks a change from during the Biden administration, when FDA officials backed plans to routinely update the COVID-19 vaccines each year.

...

FDA scrutiny of Novavax COVID-19 vaccine sparks uncertainty about other shots There’s new uncertainty about updated COVID-19 shots this fall after the Trump administration’s handling of a shot from Novavax. AP News

Country / Region Tags:

General Topic Tags:

Disease Prevention

Problem, Solution, SitRep, or ?:

Situation Report

Groups this Group Post belongs to:

- Private group -

Log in or register to post comments

Comments

Wed, 2025-04-30 18:35 — mike kraft

New uncertainty into approval of new COVID boosters

U.S. health officials inject new uncertainty into approval process for Covid boosters Confusion over the FDA delay in granting full approval to Novavax’s Covid-19 vaccine deepened over the weekend, with possible implications for Pfizer and Moderna. Helen Branswell STAT

Log in or register to post comments

Page loaded in 1.873 seconds.